D
38
-2
STI
40
-26
CA
10
-3
MCK
59
13
M
28
-3
LH
40
-2
DE
40
-2
ROK
52
2
PRU
51
-3
EQT
39
-3
EMN
52
-4
NOV
49
-3
RCL
77
-6
SWK
64
3
TEL
66
16
HPE
53
3
BBY
40
2
MCHP
41
2
UA
36
-5
A
41
7
D
38
-2
STI
40
-26
CA
10
-3
MCK
59
13
M
28
-3
LH
40
-2
DE
40
-2
ROK
52
2
PRU
51
-3
EQT
39
-3
EMN
52
-4
NOV
49
-3
RCL
77
-6
SWK
64
3
TEL
66
16
HPE
53
3
BBY
40
2
MCHP
41
2
UA
36
-5
A
41
7
Financhill
Back

BioXcel Therapeutics Quote, Financials, Valuation and Earnings

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Sell
41

BTAI
BioXcel Therapeutics

Last Price:
0.64
Seasonality Move:
71.25%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!

BioXcel Therapeutics Price Quote

$0.64
0.00 (-0.48%)
(Updated: November 4, 2024 at 5:55 PM ET)

BioXcel Therapeutics Key Stats

Sell
41
BioXcel Therapeutics (BTAI) is a Sell
Day range:
$0.64 - $0.69
52-week range:
$0.51 - $5.62
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.69
P/B ratio:
0%
Volume:
276.6K
Avg. volume:
411.3K
1-year change:
-85.35%
Market cap:
$26.2M
Revenue:
$1.4M
EPS:
$-3.56

How Much Does BioXcel Therapeutics Make?

Is BioXcel Therapeutics Growing As A Company?

  • What Is BioXcel Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 1.42%
  • What Is BioXcel Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

BioXcel Therapeutics Stock Price Performance

What Is BioXcel Therapeutics 52-Week High & Low?

BioXcel Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy BioXcel Therapeutics?

Is BioXcel Therapeutics Cash Flow Positive?

  • What Is BTAI Cash Flow From Operations?
    Cash flow from operations (TTM) is -$105.3M
  • What Is BioXcel Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $34.1M
  • What Is BioXcel Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

BioXcel Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    BTAI return on invested capital is -204.8%
  • What Is BioXcel Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -116.7%
  • What Is BTAI Return On Equity?
    ROE is a measure of profitability and is 0%

BioXcel Therapeutics Earnings Date & Stock Price

BioXcel Therapeutics Competitors

BioXcel Therapeutics Dividend Yield

BioXcel Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 69.42%
Revenue: 141.58% 0.36%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 4.20
Upside from Last Price: 553.09%

Major Shareholders

  • How many BTAI shares are owned by institutional investors?
    22.7M BTAI shares are owned by institutional investors
  • How many BTAI shares are owned by insiders?
    208.9K BTAI shares are owned by insiders